.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Medtronic
Chinese Patent Office
Cantor Fitzgerald
Dow
Moodys
McKesson
UBS
QuintilesIMS
Johnson and Johnson

Generated: July 22, 2017

DrugPatentWatch Database Preview

SERPASIL-ESIDRIX Drug Profile

« Back to Dashboard

What is the patent landscape for Serpasil-esidrix , and what generic Serpasil-esidrix alternatives are available?

Serpasil-esidrix is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in SERPASIL-ESIDRIX is hydrochlorothiazide; reserpine. There are thirty-one drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.

Summary for Tradename: SERPASIL-ESIDRIX

Patents:0
Applicants:1
NDAs:1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SERPASIL-ESIDRIX at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis
SERPASIL-ESIDRIX #1
hydrochlorothiazide; reserpine
TABLET;ORAL011878-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Novartis
SERPASIL-ESIDRIX #2
hydrochlorothiazide; reserpine
TABLET;ORAL011878-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Julphar
UBS
Daiichi Sankyo
McKesson
Boehringer Ingelheim
US Army
Teva
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot